Insights

fda

3 min read • August 4, 2021

Cannabis Research Turns Up In Bipartisan Infrastructure Bill, Would Allow Scientists To Use Marijuana From Dispensaries

3 min read • July 8, 2021

Enveric Biosciences Reports Approval From Israel’s Ministry Of Health To Begin Phase 1/2 Trial Of Triple-Combo CBD Treatment For Glioblastoma

1 min read • May 14, 2021

Compass Pathways Shares See Volume; Marijuana Moment Reports ‘FDA Clears Researchers To Study MDMA Use By Therapists Being Trained In Psychedelic Medicine’

3 min read • April 29, 2021

Jupiter Wellness Says Advances Clinical Pipeline Of CBD-Based Topical Treatments

3 min read • March 23, 2021

Neptune Wellness Solutions Inc. Announces Receipt Of Amendment To Its Health Canada License Permitting It To Sell Dried Cannabis Flower

6 min read • March 15, 2021

Lexaria Bioscience Highlights Progress In Hypertension Studies, Says All Five Studies Examining DehydraTECHTM CBD For Hypertension Are Underway

3 min read • November 1, 2020

Does CBD Hit Different For Women? The FDA Wants To Know

1 min read • September 23, 2020

Tilray Shares Spike To Session High On Volume As Traders Circulate CBD Guidance Draft Doc From FDA Related To 100 mg/mL Solution Of Cannabidiol For In Vivo Bioequivalence Study; BZ NOTE: Tilray Not Specifically Mentioned In Draft Doc

2 min read • September 10, 2020

GW Pharma Reports Its Greenwich Biosciences Subsidiary To Present Results Of Survey Highlighting Prevalence Of Cannabis Use Among People With Multiple Sclerosis

7 min read • July 30, 2020

The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic’s Blowout Quarter

1 min read • July 21, 2020

FDA Issues Draft Guidance To Encourage Cannabis-Related Clinical Research

5 min read • April 20, 2020

Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week

Latest Headlines

View All

3 min read • September 1, 2026

Chicken Or Egg? Cannabis Brands Target Seniors As Older Americans Use More Weed

8 min read • September 1, 2026

BREAKING: House Passes One‑Month Hemp Ban Delay, Setting Up Clash Over Industry’s Future

2 min read • September 1, 2026

House Moves Toward Hemp THC Ban Delay, Giving Industry More Time Before Federal Crackdown

3 min read • September 1, 2026

Ascend Wellness Takes Step Toward U.S. Exchange Listing, Gets Green Light For Reverse Stock Split

13 min read • September 1, 2026

Boris Jordan Might Be Talking Aurora’s Dispersed Shareholder Structure Into Free-Riding the Deal

6 min read • September 1, 2026

Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.

4 min read • August 31, 2026

$10 Million in Taxpayer Money Was Diverted Into Florida’s Fight Against Marijuana Legalization, Grand Jury Says

2 min read • August 28, 2026

PharmaCielo Revenue Surges 330%; European Cannabis Flower Sales Take Off

Browse By Channels

Broad U.S. Equity ETFs

first quarter earnings

illegal cannabis farms

intoxicating hemp-derived products

Macro Economic Events

Market-Moving Exclusives

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.

View Insights

Secure Access

fda

Cannabis Research Turns Up In Bipartisan Infrastructure Bill, Would Allow Scientists To Use Marijuana From Dispensaries

Enveric Biosciences Reports Approval From Israel’s Ministry Of Health To Begin Phase 1/2 Trial Of Triple-Combo CBD Treatment For Glioblastoma

Compass Pathways Shares See Volume; Marijuana Moment Reports ‘FDA Clears Researchers To Study MDMA Use By Therapists Being Trained In Psychedelic Medicine’

Jupiter Wellness Says Advances Clinical Pipeline Of CBD-Based Topical Treatments

Neptune Wellness Solutions Inc. Announces Receipt Of Amendment To Its Health Canada License Permitting It To Sell Dried Cannabis Flower

Lexaria Bioscience Highlights Progress In Hypertension Studies, Says All Five Studies Examining DehydraTECHTM CBD For Hypertension Are Underway

Does CBD Hit Different For Women? The FDA Wants To Know

Tilray Shares Spike To Session High On Volume As Traders Circulate CBD Guidance Draft Doc From FDA Related To 100 mg/mL Solution Of Cannabidiol For In Vivo Bioequivalence Study; BZ NOTE: Tilray Not Specifically Mentioned In Draft Doc

GW Pharma Reports Its Greenwich Biosciences Subsidiary To Present Results Of Survey Highlighting Prevalence Of Cannabis Use Among People With Multiple Sclerosis

The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic’s Blowout Quarter

FDA Issues Draft Guidance To Encourage Cannabis-Related Clinical Research

Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week

Chicken Or Egg? Cannabis Brands Target Seniors As Older Americans Use More Weed

BREAKING: House Passes One‑Month Hemp Ban Delay, Setting Up Clash Over Industry’s Future

House Moves Toward Hemp THC Ban Delay, Giving Industry More Time Before Federal Crackdown

Ascend Wellness Takes Step Toward U.S. Exchange Listing, Gets Green Light For Reverse Stock Split

Boris Jordan Might Be Talking Aurora’s Dispersed Shareholder Structure Into Free-Riding the Deal

Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2

Glass House, America’s Largest Cannabis Grower by Canopy, Rings the NYSE Bell

USCR Urges Congress to Keep the Hemp Loophole Closed

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 1

$10 Million in Taxpayer Money Was Diverted Into Florida’s Fight Against Marijuana Legalization, Grand Jury Says

PharmaCielo Revenue Surges 330%; European Cannabis Flower Sales Take Off

Browse By Channels

Join the Cannabis Revolution

Insights

Insights Tips